A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

Cancer Type

Carcinoma

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

For more information about this study

View Details